NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses

High Resolution Copy Number Variation Data in the NCI-60 Cancer Cell Lines from Whole Genome Microarrays Accessible through CellMiner

(2014) Sudhir Varma et al.   PLoS One

The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology

(2013) O. D. Abaan et al.   CANCER RESEARCH

Germline pharmacogenetics of paclitaxel for cancer treatment

(2013) Daniel L Hertz   PHARMACOGENOMICS

Cancer Genome Landscapes

(2013) B. Vogelstein et al.   SCIENCE

Global Proteome Analysis of the NCI-60 Cell Line Panel

(2013) Amin Moghaddas Gholami et al.   Cell Reports

Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor

(2012) Samit Patrawala et al.   Future Oncology

Systematic identification of genomic markers of drug sensitivity in cancer cells

(2012) Mathew J. Garnett et al.   NATURE

Sequence analysis of mutations and translocations across breast cancer subtypes

(2012) Shantanu Banerji et al.   NATURE

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

Cell lines battle cancer

(2012) John N. Weinstein   NATURE

Exome sequencing to find rare variants causing neurologic diseases

(2012) D. Doherty et al.   NEUROLOGY

Mass Homozygotes Accumulation in the NCI-60 Cancer Cell Lines As Compared to HapMap Trios, and Relation to Fragile Site Location

(2012) Xiaoyang Ruan et al.   PLoS One

Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents

(2012) G. Zoppoli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF  interaction

(2012) L. Cunningham et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation

(2012) M. Jain et al.   SCIENCE

Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology

(2011) Maureen Cronin et al.   Biomarkers in Medicine

Recombination phenotypes of the NCI-60 collection of human cancer cells

(2011) Dawn M Stults et al.   BMC MOLECULAR BIOLOGY

Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron

(2010) W. C. Reinhold et al.   CANCER RESEARCH

Genome-Wide mRNA and microRNA Profiling of the NCI 60 Cell-Line Screen and Comparison of FdUMP[10] with Fluorouracil, Floxuridine, and Topoisomerase 1 Poisons

(2010) W. H. Gmeiner et al.   MOLECULAR CANCER THERAPEUTICS

Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines

(2010) S. L. Holbeck et al.   MOLECULAR CANCER THERAPEUTICS

Expression Profiling of Nuclear Receptors in the NCI60 Cancer Cell Panel Reveals Receptor-Drug and Receptor-Gene Interactions

(2010) Susan Holbeck et al.   MOLECULAR ENDOCRINOLOGY

Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel

(2010) Christina H. Stuelten et al.   STEM CELLS

DNA fingerprinting of the NCI-60 cell line panel

(2009) P. L. Lorenzi et al.   MOLECULAR CANCER THERAPEUTICS

Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen

(2008) S. A. Amundson et al.   CANCER RESEARCH